Cargando…
Inference of Diagnostic Markers and Therapeutic Targets From CSF Proteomics for the Treatment of Hydrocephalus
Autores principales: | Horowitz, Arie, Saugier-Veber, Pascale, Gilard, Vianney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609871/ https://www.ncbi.nlm.nih.gov/pubmed/33192320 http://dx.doi.org/10.3389/fncel.2020.576028 |
Ejemplares similares
-
Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants
por: Marguet, Florent, et al.
Publicado: (2021) -
Murine MPDZ‐linked hydrocephalus is caused by hyperpermeability of the choroid plexus
por: Yang, Junning, et al.
Publicado: (2018) -
CSF Proteomics of Patients with Hydrocephalus and Subarachnoid Haemorrhage
por: Sokół, Bartosz, et al.
Publicado: (2019) -
Pharmacological Targeting of CSF1R Inhibits Microglial Proliferation and Aggravates the Progression of Cerebral Ischemic Pathology
por: Hou, Boru, et al.
Publicado: (2020) -
WDR43 is a potential diagnostic biomarker and therapeutic target for osteoarthritis complicated with Parkinson’s disease
por: Heng, Hongquan, et al.
Publicado: (2022)